Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
58.17
-0.68 (-1.16%)
Jun 29, 2026, 11:13 AM EDT - Market open
Travere Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Travere Therapeutics stock have an average target of 58.33, with a low estimate of 43 and a high estimate of 70. The average target predicts an increase of 0.28% from the current stock price of 58.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Travere Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $56 → $65 | Buy | Reiterates | $56 → $65 | +11.74% | Jun 25, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 → $61 | Buy | Maintains | $55 → $61 | +4.87% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $67 | Buy | Reiterates | $67 | +15.18% | Jun 22, 2026 |
| Citi | Citi | Buy Reiterates $62 → $70 | Buy | Reiterates | $62 → $70 | +20.34% | Jun 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $65 | Buy | Maintains | $50 → $65 | +11.74% | Jun 12, 2026 |
Financial Forecast
Revenue This Year
697.77M
from 490.73M
Increased by 42.19%
Revenue Next Year
968.88M
from 697.77M
Increased by 38.85%
EPS This Year
1.87
from 0.91
Increased by 105.34%
EPS Next Year
4.85
from 1.87
Increased by 159.59%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 941.1M | 1.2B | |
| Avg | 697.8M | 968.9M | |
| Low | 595.0M | 725.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 91.8% | 78.2% | |
| Avg | 42.2% | 38.9% | |
| Low | 21.2% | 3.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.80 | 7.14 | |
| Avg | 1.87 | 4.85 | |
| Low | 0.92 | 3.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 207.7% | 282.1% | |
| Avg | 105.3% | 159.6% | |
| Low | 1.1% | 73.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.